eFFECTOR Therapeutics, Inc. - stock earnings
EFTRW Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -8.3 million USD | ? USD |
| 2023Q2 | -8.4 million USD | ? USD |
| 2023Q1 | -10.0 million USD | ? USD |
| 2022Q4 | -9.3 million USD | 675000 USD |
| 2022Q3 | -9.9 million USD | 867000 USD |
| 2022Q2 | -5.9 million USD | ? USD |
| 2022Q1 | 12.7 million USD | ? USD |
| 2021Q4 | 19.0 million USD | 1.4 million USD |
| 2021Q3 | 8.9 million USD | 427000 USD |
| 2021Q2 | -5.5 million USD | ? USD |
| 2021Q1 | -6.6 million USD | ? USD |
| 2020Q4 | -5.9 million USD | 42000 USD |
| 2020Q3 | -7.6 million USD | 574000 USD |
EFTRW Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -35.9 million USD | ? USD |
| 2022 | -12.9 million USD | 3.6 million USD |
| 2021 | 15.8 million USD | 1.4 million USD |
| 2020 | 14.2 million USD | 42.0 million USD |
| 2019 | -29.7 million USD | ? USD |
EFTRW
Price: $0.03
52 week price:
Earnings Per Share: -0.91 USD
P/E Ratio: -0.12
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 3053
Market Capitalization: 23.4 million